Research & Development

BioAlliance Pharma has based its development on the principle of outsourcing basic research with a single aim in mind: to be able to work with the best experts at all times and have access to leading-edge research at an international level. The company has therefore entered into partnering arrangements consisting of alliances with the main French research centers to which BioAlliance researchers are assigned, depending on the projects in process.

BioAlliance develops its product portfolio on the basis of four core principles:

• Minimizing risks, which are ever present in the pharmaceutical industry, by working on several separate lines,
• Addressing markets where there are unmet medical needs or problems of drug resistance, in which appropriate targeting strategies may be applied.
• Keeping the development time to a minimum by working partly with already existing molecules or by opting for orphan drug status.
• Integrating all activities, from development to market.